Pharmaceuticals News and Research

RSS

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

The Pharmacy Care Alliance has announced that for the first seven weeks of its discount card program, Medicare beneficiaries saved an average of 40 percent on generic drugs and 23 percent on brand drugs when compared to retail pharmacy cash prices. Medicare beneficiaries in all U.S. states have used the Pharmacy Care Alliance card since June 1.

29 Jul 2004

Federal agencies should assess the safety of genetically altered foods, whether produced by genetic engineering or by other techniques

Federal agencies should assess the safety of genetically altered foods -- whether produced by genetic engineering or by other techniques, such as conventional breeding for desirable traits -- on a case-by-case basis to determine whether unintended changes in their composition could adversely affect human health, says a new report from the National Academies' National Research Council and Institute of Medicine.

29 Jul 2004

Research collaboration to discover novel oral drugs for the treatment of viral infections

Sunesis Pharmaceuticals, Inc. and Merck & Co., Inc. have announced that they have entered into a multi-year research collaboration to discover novel oral drugs for the treatment of viral infections.

29 Jul 2004

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

An international study with nearly 900 patients co-infected with Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) has shown that HCV can be treated effectively and safely, without compromising the patient’s HIV therapy.

29 Jul 2004

Patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu

PRB Pharmaceuticals and Lee's Pharmaceuticals have announced the discovery that PRB'S patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu (H3N2) infections in vitro.

29 Jul 2004

New process that simplifies the production of proteins

F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.

29 Jul 2004

Researchers discover a carbohydrate with an unusual structure in the cell walls of the bacterium that causes tuberculosis

Even though we have lost much of our fear of tuberculosis in the industrialized countries, according to the WHO about 2 million people worldwide die each year of this infectious disease.

28 Jul 2004

Pharmaceutical Benefits Scheme (PBS) medicines available faster

The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.

27 Jul 2004

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Merck/Schering-Plough Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved VYTORIN™ (ezetimibe/simvastatin) for the treatment of high LDL cholesterol (LDL-C) in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Emerging nanomedicine technologies could dramatically transform medical science

Emerging nanomedicine technologies could dramatically transform medical science as we know it today with their potential to address unmet medical needs and provide targeted therapy.

23 Jul 2004

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

The European Union has awarded €12 million to a network of scientists in 11 European countries and South Africa and the aim is to use plants to produce vaccines and treatments against major diseases including AIDS, rabies, diabetes and TB.

23 Jul 2004

One of the world’s most sophisticated systems for keeping electronic health records

The system, called VistA-Office Electronic Health Record, was developed by VA. A version of VistA is used at more than 1,300 VA facilities throughout the United States to maintain records on 5 million veterans who receive their health care from VA.

23 Jul 2004

AstraZeneca files for patent infringement

AstraZeneca has confirmed that it has filed a lawsuit in the U.S. District Court for the District of Delaware against the generic company Andrx for patent infringement.

23 Jul 2004

Plan B has been shown to reduce the risk of pregnancy by 89 percent

Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.

23 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Natural organohalogens have potent anticancer and antibacterial activity

Human made chemical compounds called organohalogens get loads of attention as they are best known for their often harmful effect on the environment - substances like the CFCs (the ozone-damaging chemicals), dioxin (found in the herbicide Agent Orange), PCBs (industrial fluids) and several pesticides.

22 Jul 2004

Clinical study compares treatments in early Parkinson's disease

University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.

21 Jul 2004

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Medicare could eliminate the coverage gap in its prescription drug benefit if it paid pharmaceutical prices comparable to those paid by citizens of Canada, the United Kingdom and France, according to a report by researchers from the Johns Hopkins Bloomberg School of Public Health and Pennsylvania State University

21 Jul 2004

Pharmaceuticals News and Research

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

Federal agencies should assess the safety of genetically altered foods, whether produced by genetic engineering or by other techniques

Research collaboration to discover novel oral drugs for the treatment of viral infections

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu

New process that simplifies the production of proteins

Researchers discover a carbohydrate with an unusual structure in the cell walls of the bacterium that causes tuberculosis

Pharmaceutical Benefits Scheme (PBS) medicines available faster

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Emerging nanomedicine technologies could dramatically transform medical science

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

One of the world’s most sophisticated systems for keeping electronic health records

AstraZeneca files for patent infringement

Plan B has been shown to reduce the risk of pregnancy by 89 percent

New cream treatment for common form of skin cancer

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Natural organohalogens have potent anticancer and antibacterial activity

Clinical study compares treatments in early Parkinson's disease

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Free eBook - From lab to market: Accelerate your bioprocessing journey eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring